PlainRecalls
FDA Drug Low Class III Terminated

BuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 300 mg, Rx Only, 500-count bottles, Manufactured by Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA inc. Pennington, NJ 08534, NDC 68382-354-05

Reported: November 30, 2016 Initiated: August 3, 2016 #D-0149-2017

Product Description

BuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 300 mg, Rx Only, 500-count bottles, Manufactured by Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA inc. Pennington, NJ 08534, NDC 68382-354-05

Reason for Recall

Failed Dissolution Specifications: Product did not meet dissolution specification at an intermediate time point.

Details

Units Affected
2,472 units
Distribution
Nationwide
Location
Pennington, NJ

Frequently Asked Questions

What product was recalled?
BuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 300 mg, Rx Only, 500-count bottles, Manufactured by Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA inc. Pennington, NJ 08534, NDC 68382-354-05. Recalled by Zydus Pharmaceuticals USA Inc. Units affected: 2,472 units.
Why was this product recalled?
Failed Dissolution Specifications: Product did not meet dissolution specification at an intermediate time point.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 30, 2016. Severity: Low. Recall number: D-0149-2017.